User:BiliaryBea
Editor·2,988 edits·since 2025/03
BiliaryBea is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,988Total edits
6Logged here
5Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Shanghai Sigma-Audley New Material Technology | 2 | 82 | 2% |
| Bachem Holding (Suzhou) | 1 | 86 | 1% |
| ChinaPeptides | 1 | 86 | 1% |
| Shanghai Wibson Biotechnology | 1 | 78 | 1% |
| Trial data comparison | 1 | 78 | 1% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.